Lower brain fatty acid amide hydrolase in treatment-seeking patients with alcohol use disorder: a positron emission tomography study with [C-11]CURB

The endocannabinoid enzyme, fatty acid amide hydrolase (FAAH), has been proposed as a therapeutic target for alcohol use disorder (AUD) and co-morbid psychiatric illnesses. Investigating this target in the living human brain and its relationship to clinical outcome is a critical step of informed dru...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuropsychopharmacology
Autores principales: Best, Laura M., Williams, Belinda, Le Foll, Bernard, Mansouri, Esmaeil, Bazinet, Richard P., Lin, Lin, De Luca, Vincenzo, Lagzdins, Dina, Rusjan, Pablo, Tyndale, Rachel F., Wilson, Alan A., Hendershot, Christian S., Heilig, Markus, Houle, Sylvain, Tong, Junchao, Kish, Stephen J., Boileau, Isabelle
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer International Publishing 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7298050/
https://ncbi.nlm.nih.gov/pubmed/31910433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41386-020-0606-2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares